Executive Brief
Let's Talk Risk! Podcast
Executive Brief: What FDA is Looking For in Your Tox Data to Ensure Safety
- Published
- October 9, 2026
- Duration
- 23:30
- Summary source
- description
- Last updated
- Oct 25, 2026
Discusses Robust chemical characterization is essentially the gateway to biological safety.A toxicological ris…
Summary
Robust chemical characterization is essentially the gateway to biological safety.A toxicological risk assessment is only as strong as the analytical data supporting it.FDA’s September 2026 biocompatibility town hall provided a detailed look at how the Agency is evaluating chemical characterization and toxicological evidence under ISO 10993-18. The emphasi…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Robust chemical characterization is essentially the gateway to biological safety.A toxicological risk assessment is only as strong as the analytical data supporting it.FDA’s September 2026 biocompatibility town hall provided a detailed look at how the Agency is evaluating chemical characterization and toxicological evidence under ISO 10993-18. The emphasis was not simply on whether testing was performed, but whether the resulting data are sufficiently representative, sensitive, and scientificall